BioHarvest Sciences is forecast to grow earnings and revenue by 61.1% and 29% per annum respectively while EPS is expected to grow by 62.7% per annum.
Key information
61.1%
Earnings growth rate
62.66%
EPS growth rate
Personal Products earnings growth
8.5%
Revenue growth rate
29.0%
Future return on equity
n/a
Analyst coverage
Low
Last updated
15 May 2026
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
MUN:8MV0 - Analysts future estimates and past financials data (USD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
87
10
7
19
3
12/31/2027
59
-4
-5
2
4
12/31/2026
43
-9
-14
-5
4
3/31/2026
35
-11
-9
-7
N/A
12/31/2025
35
-11
-10
-7
N/A
9/30/2025
33
-12
-9
-7
N/A
6/30/2025
30
-12
-9
-7
N/A
3/31/2025
28
-9
-10
-7
N/A
12/31/2024
25
-13
-10
-7
N/A
9/30/2024
22
-17
-10
-7
N/A
6/30/2024
19
-16
-9
-7
N/A
3/31/2024
16
-18
-10
-8
N/A
12/31/2023
13
-13
-10
-9
N/A
9/30/2023
11
-8
-9
-8
N/A
6/30/2023
9
-10
-11
-10
N/A
3/31/2023
7
-10
-10
-8
N/A
12/31/2022
5
-11
-10
-9
N/A
9/30/2022
4
-10
-10
-9
N/A
6/30/2022
3
-9
-10
-8
N/A
3/31/2022
2
-5
-10
-8
N/A
12/31/2021
2
-10
-8
-7
N/A
9/30/2021
2
-11
-7
-6
N/A
6/30/2021
1
-10
-7
-6
N/A
3/31/2021
1
-13
-5
-4
N/A
12/31/2020
0
-7
-4
-4
N/A
9/30/2020
0
-5
-3
-3
N/A
6/30/2020
0
-5
-2
-2
N/A
3/31/2020
0
-4
-3
-3
N/A
12/31/2019
0
-5
N/A
-2
N/A
9/30/2019
0
-5
N/A
-3
N/A
12/31/2018
0
-7
N/A
-3
N/A
12/31/2017
0
-2
N/A
-2
N/A
12/31/2016
0
-3
N/A
-2
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8MV0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).
Earnings vs Market: 8MV0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 8MV0 is expected to become profitable in the next 3 years.
Revenue vs Market: 8MV0's revenue (29% per year) is forecast to grow faster than the German market (6.8% per year).
High Growth Revenue: 8MV0's revenue (29% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 8MV0's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/08 04:15
End of Day Share Price
2026/07/06 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioHarvest Sciences Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.